Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia.
about
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant SchizophreniaAssociative learning beyond the medial temporal lobe: many actors on the memory stagePrefrontal Activity and Connectivity with the Basal Ganglia during Performance of Complex Cognitive Tasks Is Associated with Apathy in Healthy SubjectsSynapse assembly and neurodevelopmental disordersFunctional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior.Common variants in the MKL1 gene confer risk of schizophrenia.FXR1P is a GSK3β substrate regulating mood and emotion processing.Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics.How much do we know about the coupling of G-proteins to serotonin receptors?Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.Meta-analysis demonstrates lack of association of the GSK3B -50C/T polymorphism with risk of bipolar disorder.DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia.Aversive emotional interference impacts behavior and prefronto-striatal activity during increasing attentional control.Modeling a linkage between blood transcriptional expression and activity in brain regions to infer the phenotype of schizophrenia patients.Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2Combined effect of genetic variants in the GluN2B coding gene (GRIN2B) on prefrontal function during working memory performance.Disparate Effects of Lithium and a GSK-3 Inhibitor on Neuronal Oscillatory Activity in Prefrontal Cortex and Hippocampus.Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment.
P2860
Q26773403-9D4F2918-8354-4B06-9B68-4633C73278F4Q27013689-969F1091-22B8-4EDC-A0BB-61EA8BF837F6Q28109662-752E9B11-F0C6-4BA1-9A5F-C3E4AFF630DDQ34675836-B80E7AE7-5E0A-4E7C-96CA-3D351D2DBF1BQ34906834-02D860A7-455D-44D7-AD9E-6F9C70BED9C8Q35369852-E4BF8CFC-A9C6-4E74-A441-956224F2D826Q35990042-00E101ED-5D91-417A-87DA-F276B3A8E95CQ37024867-BE4D7448-3E90-421E-8412-591D300B63E4Q38228106-49998266-F239-4CC4-8F65-DC5E4AAF7C09Q38266162-645E1AC6-5BE4-4802-B3B0-E1B8168B625AQ38397184-A32D25D5-B919-4A08-83A6-E8FFDE93C68BQ39017080-EF46D2CA-54D4-48A2-BB81-422DA9A184D2Q39836000-04860FD4-32B2-4ECD-8241-F93A266281C1Q41538265-02E2D0F8-DBF0-4AEE-83C2-9BBE979F7865Q41867856-78008DD3-6D4E-431E-A950-5920D09FEBD8Q49118529-1AFFE594-D245-4D31-8843-F2802EA7836FQ49333511-A62E6A8F-55F3-488F-A664-09CF38358F5EQ54352444-A886C844-3E77-4DEB-AF58-18BEDC99BB6D
P2860
Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Association of GSK-3β genetic ...... physiology, and schizophrenia.
@en
Association of GSK-3β genetic ...... physiology, and schizophrenia.
@nl
type
label
Association of GSK-3β genetic ...... physiology, and schizophrenia.
@en
Association of GSK-3β genetic ...... physiology, and schizophrenia.
@nl
prefLabel
Association of GSK-3β genetic ...... physiology, and schizophrenia.
@en
Association of GSK-3β genetic ...... physiology, and schizophrenia.
@nl
P2093
P50
P1476
Association of GSK-3β genetic ...... physiology, and schizophrenia
@en
P2093
Alessandro Bertolino
Annamaria Porcelli
Antonio Rampino
Barbara Gelao
Barbara K Lipska
Daniel R Weinberger
Gianluca Ursini
Giovanna Todarello
Grazia Caforio
Joel E Kleinman
P304
P356
10.1176/APPI.AJP.2012.12070908
P407
P50
P577
2013-08-01T00:00:00Z